{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:02:56Z","timestamp":1789995776367,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014902","name":"Irish Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival rates and rising global incidence. Despite research advances, no validated liquid biopsy biomarkers currently exist for OAC. Extracellular vesicles (EV), due to their role in intercellular communication and ability to carry molecular cargo, represent a promising source of diagnostic and prognostic biomarkers. This study explores the proteomic profiles of EV-enriched preparations derived from serum and adipose-conditioned media (ACM) of OAC patients and non-cancer controls. EV-enriched preparations were isolated using size exclusion chromatography and analysed via label-free liquid chromatography\u2013mass spectrometry. Bioinformatic analysis included principal component analysis and pathway analysis. Kaplan-Meier survival analysis using public datasets evaluated the prognostic relevance of candidate EV proteins. Proteomic profiling identified 65 differentially expressed proteins in serum-derived EV-enriched preparations from OAC patients, enriched in angiogenesis and migration pathways. In adipose tissue-derived EV-enriched preparations, 680 proteins were differentially expressed in OAC patients, with 118 altered between people with obesity and people without obesity. Comparative analysis revealed six consistently upregulated proteins in both serum and adipose-derived EV-enriched preparations: MYL6, VCP, HSP90AB1, CLTC, CCT7, and TCP1. Of these, HSP90AB1, CCT7, and TCP1 were significantly associated with poorer overall survival. These results highlight the role of EV-enriched proteins in tumour progression and immune modulation. This study offers novel biomarker candidates for OAC diagnosis and prognosis, especially in the context of obesity. The identification of clinically relevant proteomic signatures supports the potential of EV-based liquid biopsies for non-invasive disease monitoring and personalised therapeutic strategies in OAC.<\/jats:p>","DOI":"10.1038\/s41598-026-59243-x","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:39:10Z","timestamp":1782401950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum and adipose tissue-derived extracellular vesicles as biomarker reservoirs in oesophageal adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Aisling B.","family":"Heeran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling U\u00ed","family":"Mhaonaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria Lima","family":"Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshul","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanasamy","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriele","family":"Prina-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacintha O`","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Marcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"59243_CR1","unstructured":"F.-N.B.W. Group., BEST (Biomarkers, EndpointS, and other Tools) Resource 2016."},{"key":"59243_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263 (2022).","journal-title":"Cancer J. Clin."},{"key":"59243_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold, M., Ferlay, J., van Berge Henegouwen, M. I. & Soerjomataram, I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut 69, 1564\u20131571 (2020).","journal-title":"Gut"},{"key":"59243_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/gutjnl-2020-321089","volume":"70","author":"E Morgan","year":"2021","unstructured":"Morgan, E. et al. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut 70, 234\u2013242 (2021).","journal-title":"Gut"},{"key":"59243_CR5","unstructured":"C. Th\u00e9ry, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell. Vesicles, 7, 1535750. (2018)."},{"key":"59243_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102825","author":"M Mathew","year":"2020","unstructured":"Mathew, M. et al. Extracellular Vesicles as Biomarkers in Cancer Immunotherapy. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12102825 (2020).","journal-title":"Cancers (Basel)"},{"key":"59243_CR7","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol. 10, 1470\u20131476 (2008).","journal-title":"Nat. Cell. Biol."},{"key":"59243_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2407-9-244","volume":"9","author":"J Li","year":"2009","unstructured":"Li, J. et al. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer. 9, 244 (2009).","journal-title":"BMC Cancer"},{"key":"59243_CR9","doi-asserted-by":"publisher","first-page":"86999","DOI":"10.18632\/oncotarget.13569","volume":"7","author":"SN Hurwitz","year":"2016","unstructured":"Hurwitz, S. N. et al. Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget 7, 86999\u201387015 (2016).","journal-title":"Oncotarget"},{"key":"59243_CR10","doi-asserted-by":"crossref","unstructured":"Bernardi, S. et al. Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules. Front. Oncol., Volume 13\u20132023 (2024).","DOI":"10.3389\/fonc.2023.1239042"},{"key":"59243_CR11","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1182\/blood-2023-185733","volume":"142","author":"S Bernardi","year":"2023","unstructured":"Bernardi, S. et al. Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients. Blood 142, 3180\u20133180 (2023).","journal-title":"Blood"},{"key":"59243_CR12","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1038\/s41467-021-22913-7","volume":"12","author":"F Tian","year":"2021","unstructured":"Tian, F. et al. Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer. Nat. Commun. 12, 2536 (2021).","journal-title":"Nat. Commun."},{"key":"59243_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/ijc.31553","volume":"143","author":"X Fang","year":"2018","unstructured":"Fang, X. et al. Quantitative association between body mass index and the risk of cancer: A global Meta-analysis of prospective cohort studies. Int. J. Cancer. 143, 1595\u20131603 (2018).","journal-title":"Int. J. Cancer"},{"key":"59243_CR14","doi-asserted-by":"publisher","first-page":"j477","DOI":"10.1136\/bmj.j477","volume":"356","author":"M Kyrgiou","year":"2017","unstructured":"Kyrgiou, M. et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. Bmj 356, j477 (2017).","journal-title":"Bmj"},{"key":"59243_CR15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","volume":"387","author":"Trends in adult","year":"2016","unstructured":"Trends in adult. body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants. Lancet 387, 1377\u20131396 (2016).","journal-title":"Lancet"},{"key":"59243_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar, M. A. et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal. Transduct. Target. Ther. 9, 27 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2024","key":"59243_CR17","first-page":"e70009","volume":"5","author":"Y Ma","year":"2020","unstructured":"Ma, Y., Zhang, X., Liu, C. & Zhao, Y. Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies. MedComm 5 (2024), e70009 (2020).","journal-title":"MedComm"},{"key":"59243_CR18","doi-asserted-by":"crossref","unstructured":"Sullivan, R. et al. The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond, Frontiers in Endocrinology, Volume 8\u20132017 (2017).","DOI":"10.3389\/fendo.2017.00194"},{"key":"59243_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133328","author":"JA Moraes","year":"2021","unstructured":"Moraes, J. A. et al. Adipose Tissue-Derived Extracellular Vesicles and the Tumor Microenvironment: Revisiting the Hallmarks of Cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13133328 (2021).","journal-title":"Cancers (Basel)"},{"key":"59243_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park, J., Morley, T. S., Kim, M., Clegg, D. J. & Scherer, P. E. Obesity and cancer\u2013mechanisms underlying tumour progression and recurrence. Nat. Rev. Endocrinol. 10, 455\u2013465 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"59243_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061681","author":"F O\u2019Connell","year":"2023","unstructured":"O\u2019Connell, F. et al. Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma. Cancers https:\/\/doi.org\/10.3390\/cancers15061681 (2023).","journal-title":"Cancers"},{"key":"59243_CR22","unstructured":"E.E.U.N.C. Laboratory. Measuring the Size and Concentration of Nanoparticles using Particle Tracking Analysis (PTA), (2018)."},{"key":"59243_CR23","doi-asserted-by":"crossref","unstructured":"Ender, F., Zamzow, P., Bubnoff, N. V. & Gieseler, F. Detection and Quantification of Extracellular Vesicles via FACS: Membrane Labeling Matters! Int. J. Mol. Sci., 21 (2019).","DOI":"10.3390\/ijms21010291"},{"key":"59243_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41598-024-83742-4","volume":"15","author":"LE Kane","year":"2025","unstructured":"Kane, L. E. et al. Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development. Sci. Rep. 15, 129 (2025).","journal-title":"Sci. Rep."},{"key":"59243_CR25","first-page":"100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy, B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov. (Camb). 5, 100625 (2024).","journal-title":"Innov. (Camb)"},{"key":"59243_CR26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fnins.2019.01067","volume":"13","author":"YXF Lee","year":"2019","unstructured":"Lee, Y. X. F., Johansson, H. & Wood, M. J. A. El Andaloussi, Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale. Front. Neurosci. 13, 1067 (2019).","journal-title":"Front. Neurosci."},{"key":"59243_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1210\/clinem\/dgab756","volume":"107","author":"P Hruska","year":"2022","unstructured":"Hruska, P. et al. Bienertova-Vasku, Proteomic Signatures of Human Visceral and Subcutaneous Adipocytes. J. Clin. Endocrinol. Metab. 107, 755\u2013775 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"59243_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"59243_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s42003-019-0609-x","volume":"2","author":"SY Ko","year":"2019","unstructured":"Ko, S. Y. et al. Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake. Commun. Biol. 2, 386 (2019).","journal-title":"Commun. Biol."},{"key":"59243_CR30","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1158\/0008-5472.CAN-11-0241","volume":"71","author":"C Grange","year":"2011","unstructured":"Grange, C. et al. Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche. Cancer Res. 71, 5346\u20135356 (2011).","journal-title":"Cancer Res."},{"key":"59243_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.canlet.2020.10.009","volume":"497","author":"X Zheng","year":"2021","unstructured":"Zheng, X. et al. Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells. Cancer Lett. 497, 190\u2013201 (2021).","journal-title":"Cancer Lett."},{"key":"59243_CR32","doi-asserted-by":"publisher","first-page":"100520","DOI":"10.1016\/j.mcpro.2023.100520","volume":"22","author":"W Zhou","year":"2023","unstructured":"Zhou, W. et al. Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell. Mol. Cell. Proteom. 22, 100520 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"59243_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body Fatness and Cancer\u2013Viewpoint of the IARC Working Group. N Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N Engl. J. Med."},{"key":"59243_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fimmu.2020.00245","volume":"11","author":"I B\u00e4hr","year":"2020","unstructured":"B\u00e4hr, I., Spielmann, J., Quandt, D. & Kielstein, H. Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer. Front. Immunol. 11, 245 (2020).","journal-title":"Front. Immunol."},{"key":"59243_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590794","volume":"11","author":"JT Gibson","year":"2020","unstructured":"Gibson, J. T. et al. Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer. Front Immunol 11, 590794 (2020).","journal-title":"Front Immunol"},{"key":"59243_CR36","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel, A. E. et al. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity. Cell 183, 1848-1866e.e1826 (2020).","journal-title":"Cell"},{"key":"59243_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108925","volume":"9","author":"M Lundholm","year":"2014","unstructured":"Lundholm, M. et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8\u2009+\u2009T cells: mechanism of immune evasion. PLoS One 9, e108925 (2014).","journal-title":"PLoS One"},{"key":"59243_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imlet.2018.05.002","volume":"199","author":"Y Ning","year":"2018","unstructured":"Ning, Y. et al. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response. Immunol Lett 199, 36\u201343 (2018).","journal-title":"Immunol Lett"},{"key":"59243_CR39","doi-asserted-by":"crossref","unstructured":"Zhao, J. et al. Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer, Cancers, (2019).","DOI":"10.3390\/cancers11060874"},{"key":"59243_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41586-021-04234-3","volume":"601","author":"R Garcia-Martin","year":"2022","unstructured":"Garcia-Martin, R. et al. MicroRNA sequence codes for small extracellular vesicle release and cellular retention. Nature 601, 446\u2013451 (2022).","journal-title":"Nature"},{"key":"59243_CR41","doi-asserted-by":"crossref","unstructured":"Watanabe, S., Sato, R., Sasaki, T., Takahashi, Y. & Yamauchi, Y. Proteomic profiling of tissue extracellular vesicles (EVs) identifies tissue-specific EV markers and predicts the accessibility of tissue EVs to the circulation, bioRxiv, (2025) 2025.2003.2006.641016.","DOI":"10.1101\/2025.03.06.641016"},{"key":"59243_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5306\/wjco.v14.i10.373","volume":"14","author":"Q Li","year":"2023","unstructured":"Li, Q. & Yin, L. K. Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer. World J Clin Oncol 14, 373\u2013399 (2023).","journal-title":"World J Clin Oncol"},{"key":"59243_CR43","doi-asserted-by":"publisher","first-page":"747","DOI":"10.18632\/aging.203809","volume":"14","author":"X Huang","year":"2022","unstructured":"Huang, X. et al. Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma. Aging (Albany NY) 14, 747\u2013769 (2022).","journal-title":"Aging (Albany NY)"},{"key":"59243_CR44","unstructured":"Hoshino, A. et al. (2020). E.M. O\u2019Reilly, D. Kelsen, T.M. Trippett, D.R. Jones, I.R. Matei, W.R. Jarnagin, D. Lyden, Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers, Cell, 182 1044\u20131061e1018 ."},{"key":"59243_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13048-021-00832-x","volume":"14","author":"H Weng","year":"2021","unstructured":"Weng, H., Feng, X., Lan, Y. & Zheng, Z. TCP1 regulates PI3K\/AKT\/mTOR signaling pathway to promote proliferation of ovarian cancer cells. J. Ovarian Res. 14, 82 (2021).","journal-title":"J. Ovarian Res."},{"key":"59243_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3393\/ac.2020.00899.0128","volume":"38","author":"Y Lim","year":"2022","unstructured":"Lim, Y. et al. Proteomic identification of arginine-methylated proteins in colon cancer cells and comparison of messenger RNA expression between colorectal cancer and adjacent normal tissues. Ann. Coloproctol. 38, 60\u201368 (2022).","journal-title":"Ann. Coloproctol"},{"key":"59243_CR47","first-page":"2169","volume":"9","author":"N Shan","year":"2016","unstructured":"Shan, N., Zhou, W., Zhang, S. & Zhang, Y. Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis. Onco Targets Ther. 9, 2169\u20132179 (2016).","journal-title":"Onco Targets Ther."},{"key":"59243_CR48","doi-asserted-by":"crossref","unstructured":"Hallal, S. et al. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance, Proteomics, 19 e1800157. (2019).","DOI":"10.1002\/pmic.201800157"},{"key":"59243_CR49","doi-asserted-by":"publisher","first-page":"153303382211182","DOI":"10.1177\/15330338221118202","volume":"21","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma. Technol. Cancer Res. Treat. 21, 15330338221118202 (2022).","journal-title":"Technol. Cancer Res. Treat."},{"key":"59243_CR50","doi-asserted-by":"crossref","unstructured":"Lin, T., Qiu, Y., Peng, W. & Peng, L. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer, Biomed Res Int, (2020) 2148253. (2020).","DOI":"10.1155\/2020\/2148253"},{"key":"59243_CR51","doi-asserted-by":"crossref","unstructured":"Costantini, S., Capone, F., Polo, A., Bagnara, P. & Budillon, A. Valosin-Containing Protein (VCP)\/p97: A Prognostic Biomarker and Therapeutic Target in Cancer. Int. J. Mol. Sci., 22 (2021).","DOI":"10.3390\/ijms221810177"},{"key":"59243_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2019.09.012","volume":"72","author":"D Caballero-D\u00edaz","year":"2020","unstructured":"Caballero-D\u00edaz, D. et al. Clathrin switches transforming growth factor-\u03b2 role to pro-tumorigenic in liver cancer. J. Hepatol. 72, 125\u2013134 (2020).","journal-title":"J. Hepatol."},{"key":"59243_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12964-023-01408-6","volume":"22","author":"K H\u00e1n\u011blov\u00e1","year":"2024","unstructured":"H\u00e1n\u011blov\u00e1, K., Raudensk\u00e1, M., Masa\u0159\u00edk, M. & Balvan, J. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. Cell. Communication Signal. 22, 25 (2024).","journal-title":"Cell. Communication Signal."},{"key":"59243_CR54","doi-asserted-by":"publisher","first-page":"e70901","DOI":"10.1111\/jcmm.70901","volume":"29","author":"S Mutti","year":"2025","unstructured":"Mutti, S. et al. Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles. J. Cell. Mol. Med. 29, e70901 (2025).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59243-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59243-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59243-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:09:32Z","timestamp":1789992572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59243-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59243"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59243-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of St James\u2019s Hospital\/AMNCH (SJH\/TUH Joint Research Ethics: 31853185).","order":2,"name":"Ethics","label":"Institutional review board","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29258"}}